| User's Publication |
|
21336
Peng S, Wang Z, Tang P, Wang S, Huang Y, Xie Q, Wang Y, Tan X, Tang T, Yan X, Xu J, Lan W, Wang L, Zhang D, Wang B, Pan T, Qin J, Jiang J, Liu Q.
PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma.
Sci Adv
2023
9(31):eadf3566
PubMed ID: 37531433
DOI: 10.1126/sciadv.adf3566
|
|
17666
Nitta S, Kandori S, Tanaka K, Sakka S, Siga M, Nagumo Y, Negoro H, Kojima T, Mathis BJ, Shimazui T, Miyamoto T, Matsuzaka T, Shimano H, Nishiyama H.
ELOVL5-mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma
Cancer Sci
2022
113(8):2738-2752
PubMed ID: 35670054
DOI: 10.1111/cas.15454
|
|
18231
Grubb T, Maganti S, Krill-Burger JM, Fraser C, Stransky L, Radivoyevitch T, Sarosiek KA, Vazquez F, Kaelin WG, Chakraborty AA.
A Mesenchymal Tumor Cell State Confers Increased Dependency on the BCL-XL Antiapoptotic Protein in Kidney Cancer
Clin Cancer Res
2022
28(21):4689-4701
PubMed ID: 35776130
DOI: 10.1158/1078-0432.CCR-22-0669
|
|
14882
Miyakuni K, Nishida J, Koinuma D, Nagae G, Aburatani H, Miyazono K, Ehata S.
Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH as a tumor suppressor in renal cancer
Mol Oncol
2022
Jun 16.
PubMed ID: 34133843
DOI: 10.1002/1878-0261.13040
|
|
20452
Tanaka K, Kandori S, Sakka S, Nitta S, Tanuma K, Shiga M, Nagumo Y, Negoro H, Kojima T, Mathis BJ, Shimazui T, Watanabe M, Sato TA, Miyamoto T, Matsuzaka T, Shimano H, Nishiyama H.
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.
Oncol Rep
2022
47(2)
PubMed ID: 34841437
DOI: 10.3892/or.2021.8234
|
|
20706
Nishida J, Miyakuni K, Miyazono K, Ehata S.
An in vivo orthotopic serial passaging model for a metastatic renal cancer study.
STAR Protoc
2022
3(2):101306
PubMed ID: 35496785
DOI: 10.1016/j.xpro.2022.101306
|
|
16501
Maishi N, Sakurai Y, Hatakeyama H, Umeyama Y, Nakamura T, Endo R, Alam MT, Li C, Annan DA, Kikuchi H, Morimoto H, Morimoto M, Akiyama K, Ohga N, Hida Y, Harashima H, Hida K.
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system
Cancer Sci
2022
113(5):1855-1867
PubMed ID: 35266253
DOI: 10.1111/cas.15323
|
|
19294
Kawatani M, Aono H, Shimizu T, Ohkura S, Hiranuma S, Muroi M, Ogawa N, Ohishi T, Ohba SI, Kawada M, Yamazaki K, Dan S, Osada H.
Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth
ACS Chem Biol
2021
16(11):2570-2580
PubMed ID: 34730931
DOI: 10.1021/acschembio.1c00625
|
|
20130
Muramatsu-Maekawa Y, Kawakami K, Fujita Y, Takai M, Kato D, Nakane K, Kato T, Tsuchiya T, Koie T, Miura Y, Ito M, Mizutani K.
Profiling of Serum Extracellular Vesicles Reveals miRNA-4525 as a Potential Biomarker for Advanced Renal Cell Carcinoma.
Cancer Genomics Proteomics
2021
18(3):253-259
PubMed ID: 33893078
DOI: 10.21873/cgp.20256
|
|
14869
Torii C, Maishi N, Kawamoto T, Morimoto M, Akiyama K, Yoshioka Y, Minami T, Tsumita T, Alam MT, Ochiya T, Hida Y, Hida K.
miRNA-1246 in extracellular vesicles secreted from metastatic tumor induces drug resistance in tumor endothelial cells
Sci Rep
2021
11(1):13502
PubMed ID: 34226586
DOI: 10.1038/s41598-021-92879-5
|
|
16105
Sasaki K, Nishina S, Yamauchi A, Fukuda K, Hara Y, Yamamura M, Egashira K, Hino K.
Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice
Cell Mol Gastroenterol Hepatol
2021
11(3):739-762
PubMed ID: 33191170
DOI: 10.1016/j.jcmgh.2020.10.010
|
|
16366
Emberley E, Pan A, Chen J, Dang R, Gross M, Huang T, Li W, MacKinnon A, Singh D, Sotirovska N, Steggerda SM, Wang T, Parlati F.
The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma
PLoS One
2021
16(11):e0259241
PubMed ID: 34731180
DOI: 10.1371/journal.pone.0259241
|
|
17038
Momoi Y, Nishida J, Miyakuni K, Kuroda M, Kubota SI, Miyazono K, Ehata S.
Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness
Cancer Sci
2021
112(8):3136-3149
PubMed ID: 34091990
DOI: 10.1111/cas.15007
|
|
12059
Sakurai Y, Kato A, Harashima H.
Involvement of Caveolin-1-mediated transcytosis in the intratumoral accumulation of liposomes.
Biochem. Biophys. Res. Commun.
2020
PubMed ID: 32087973
DOI: 10.1016/j.bbrc.2020.02.086
|
|
12102
Nishida J, Momoi Y, Miyakuni K, Tamura Y, Takahashi K, Koinuma D, Miyazono K, Ehata S.
Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis.
Nat. Cell Biol.
2020
PubMed ID: 32203421
DOI: 10.1038/s41556-020-0491-2
|
|
13132
Horie K, Kawakami K, Fujita Y, Matsuda Y, Arai T, Suzui N, Miyazaki T, Koie T, Mizutani K, Ito M.
Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.
Oncology
2020
PubMed ID: 32726790
DOI: 10.1159/000508688
|
|
12326
Taguchi L, Miyakuni K, Morishita Y, Morikawa T, Fukayama M, Miyazono K, Ehata S.
c-Ski accelerates renal cancer progression by attenuating transforming growth factor β signaling
Cancer Sci
2019
110(6):2063-2074
PubMed ID: 30972853
DOI: 10.1111/cas.14018
|
|
18124
Shelar S, Shim EH, Brinkley GJ, Kundu A, Carobbio F, Poston T, Tan J, Parekh V, Benson D, Crossman DK, Buckhaults PJ, Rakheja D, Kirkman R, Sato Y, Ogawa S, Dutta S, Velu SE, Emberley E, Pan A, Chen J, Huang T, Absher D, Becker A, Kunick C, Sudarshan S.
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer
Clin Cancer Res
2018
24(24):6433-6446
PubMed ID: 30108105
DOI: 10.1158/1078-0432.CCR-18-1727
|
|
10739
Nishida J, Miyazono K, Ehata S.
Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms.
Oncogene
2018
37:2197-2212
PubMed ID: 29391598
DOI: 10.1038/s41388-017-0084-0
|
|
10839
Tsuchida A, Senda M, Ito A, Saito S, Kiso M, Ando T, Harduin-Lepers A, Matsuda A, Furukawa K, Furukawa K.
Roles of GalNAc-disialyl Lactotetraosyl Antigens in Renal Cancer Cells.
Sci Rep
2018
8:7017
PubMed ID: 29728594
DOI: 10.1038/s41598-018-25521-6
|
|
10073
Yue D, Wang Y, Sun Y, Niu Y, Chang C.
C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
Neoplasia
2017
19:135-144
PubMed ID: 28107702
DOI: 10.1016/j.neo.2016.12.003
|
|
10482
Horie K, Kawakami K, Fujita Y, Sugaya M, Kameyama K, Mizutani K, Deguchi T, Ito M.
Exosomes expressing carbonic anhydrase 9 promote angiogenesis.
Biochem. Biophys. Res. Commun.
2017
492:356-361
PubMed ID: 28851650
DOI: 10.1016/j.bbrc.2017.08.107
|
|
12640
Kibria G, Hatakeyama H, Sato Y, Harashima H.
Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors
Int J Pharm
2016
509(1-2):178-187
PubMed ID: 27234700
DOI: 10.1016/j.ijpharm.2016.05.047
|
|
12879
Mizutani A, Koinuma D, Seimiya H, Miyazono K.
The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma
Oncogene
2016
35(27):3514-23
PubMed ID: 26522722
DOI: 10.1038/onc.2015.412
|
|
12964
Kato T, Inoue H, Imoto S, Tamada Y, Miyamoto T, Matsuo Y, Nakamura Y, Park JH.
Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells
Oncotarget
2016
7(14):17652-64
PubMed ID: 26933922
DOI: 10.18632/oncotarget.7755
|
|
14004
Zhang X, Zong W, Hu Y, Luo N, Cheng W, Han X.
A pH-responsive asymmetric lipid vesicle as drug carrier
J Microencapsul
2016
33(7):663-668
PubMed ID: 27682414
DOI: 10.1080/02652048.2016.1242668
|
|
7122
Mizutani K, Tomoda M, Ohno Y, Hayashi H, Fujita Y, Kawakami K, Kameyama K, Kato T, Sugiyama T, Itoh Y, Ito M, Deguchi T.
Effects of Cabazitaxel in Renal Cell Carcinoma Cell Lines.
Anticancer Res.
2015
35:6671-7
PubMed ID: 26637883
|
|
3744
Nakamura R, Oyama T, Tajiri R, Mizokami A, Namiki M, Nakamoto M, Ooi A.
Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma.
Cancer Sci
2015
106(5):656-64
PubMed ID: 25726761
DOI: 10.1111/cas.12649
|
|
6174
Gao F, Wang J, Ji G, Liu S, Yao Y, Wang T, Wu H, Xia Y, Gong D, Jiang H, Yang H, Zhang X.
Clustering of Cancer Cell Lines Using A Promoter- Targeted Liquid Hybridization Capture-Based Bisulfite Sequencing Approach.
Technol Cancer Res Treat
2015
14(4):383-94.
PubMed ID: 26269607
DOI: 10.1177/1533034614500416
|
|
6336
Chen Y, Sun Y, Rao Q, Xu H, Li L, Chang C.
Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
Oncotarget
2015
6(31):31203-15
PubMed ID: 26304926
DOI: 10.18632/oncotarget.4522
|
|
15128
Yamaguchi A, Usami K, Shimabe M, Hasegawa K, Asada M, Motoki K, Tahara T, Masuda K.
The novel CA IX inhibition antibody chKM4927 shows anti-tumor efficacy in vivo
Anticancer Res
2015
35(4):1997-2004
PubMed ID: 25862852
|
|
3327
Liu Y, Xu Y, Li X, Chen Z.
Smad4 suppresses the progression of renal cell carcinoma via the activation of forkhead box protein H1
Mol Med Rep
2015
11(4):2717-22
PubMed ID: 25482028
DOI: 10.3892/mmr.2014.3061
|
|
9957
Ara MN, Matsuda T, Hyodo M, Sakurai Y, Ohga N, Hida K, Harashima H.
Construction of an aptamer modified liposomal system targeted to tumor endothelial cells.
Biol. Pharm. Bull.
2014
37:1742-9
PubMed ID: 25366480
DOI: 10.1248/bpb.b14-00338
|
|
5280
Otsubo T, Hida Y, Ohga N, Sato H, Kai T, Matsuki Y, Takasu H, Akiyama K, Maishi N, Kawamoto T, Shinohara N, Nonomura K, Hida K.
Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells.
Cancer Sci
2014
105(5):560-7
PubMed ID: 24602018
DOI: 10.1111/cas.12394
|
|
15814
Alam MT, Nagao-Kitamoto H, Ohga N, Akiyama K, Maishi N, Kawamoto T, Shinohara N, Taketomi A, Shindoh M, Hida Y, Hida K.
Suprabasin as a novel tumor endothelial cell marker
Cancer Sci
2014
105(12):1533-40
PubMed ID: 25283635
DOI: 10.1111/cas.12549
|
|
18854
Kibria G, Hatakeyama H, Ohga N, Hida K, Harashima H.
The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells
Biomaterials
2013
34(22):5617-27
PubMed ID: 23623323
DOI: 10.1016/j.biomaterials.2013.03.094
|
|
6080
Akiyama K, Ohga N, Maishi N, Hida Y, Kitayama K, Kawamoto T, Osawa T, Suzuki Y, Shinohara N, Nonomura K, Shindoh M, Hida K.
The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma.
Pathol Int
2013
63(1):37-44
PubMed ID: 23356224
DOI: 10.1111/pin.12031
|
|
12239
Yu Sakurai, Hiroto Hatakeyama, Yusuke Sato, Mamoru Hyodo, Hidetaka Akita, Hideyoshi Harashima
Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system
Mol Ther
2013
21(6):1195-203
PubMed ID: 23568259
DOI: 10.1038/mt.2013.57
|
|
15790
Vanharanta S, Shu W, Brenet F, Hakimi AA, Heguy A, Viale A, Reuter VE, Hsieh JJ, Scandura JM, Massagué J.
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
Nat Med
2013
19(1):50-6
PubMed ID: 23223005
DOI: 10.1038/nm.3029
|
|
6100
Maishi N, Ohga N, Hida Y, Akiyama K, Kitayama K, Osawa T, Onodera Y, Shinohara N, Nonomura K, Shindoh M, Hida K.
CXCR7: a novel tumor endothelial marker in renal cell carcinoma.
Pathol Int
2012
62(5):309-17
PubMed ID: 22524658
DOI: 10.1111/j.1440-1827.2012.02792.x
|
|
16647
Suma T, Miyata K, Anraku Y, Watanabe S, Christie RJ, Takemoto H, Shioyama M, Gouda N, Ishii T, Nishiyama N, Kataoka K.
Smart multilayered assembly for biocompatible siRNA delivery featuring dissolvable silica, endosome-disrupting polycation, and detachable PEG
ACS Nano
2012
6(8):6693-705
PubMed ID: 22835034
DOI: 10.1021/nn301164a
|
|
7814
Ito H, Honda K, Satow R, Arai E, Shitashige M, Ono M, Sakuma T, Sakano S, Naito K, Matsuyama H, Yamada T.
Combined functional genome survey of therapeutic targets for clear cell carcinoma of the kidney.
Jpn. J. Clin. Oncol.
2011
41:847-53
PubMed ID: 21576114
DOI: 10.1093/jjco/hyr060
|
|
19029
Kanamori-Katayama M, Kaiho A, Ishizu Y, Okamura-Oho Y, Hino O, Abe M, Kishimoto T, Sekihara H, Nakamura Y, Suzuki H, Forrest AR, Hayashizaki Y.
LRRN4 and UPK3B are markers of primary mesothelial cells
PLoS One
2011
6(10):e25391
PubMed ID: 21984916
DOI: 10.1371/journal.pone.0025391
|
|
3516
Takaoka N, Takayama T, Teratani T, Sugiyama T, Mugiya S, Ozono S.
Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell lines.
BMC Mol Biol
2011
12:31
PubMed ID: 21771320
DOI: 10.1186/1471-2199-12-31
|
|
8278
Tsuchiya K, Hida K, Hida Y, Muraki C, Ohga N, Akino T, Kondo T, Miseki T, Nakagawa K, Shindoh M, Harabayashi T, Shinohara N, Nonomura K, Kobayashi M.
Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.
Int. J. Oncol.
2010
36:1379-86
PubMed ID: 20428760
DOI: 10.3892/ijo_00000622
|
|
8328
Umebayashi M, Makizono T, Ichihara H, Matsumoto Y, Ueoka R.
Inhibitory effects of cationic hybrid liposomes on the growth of human renal cell carcinoma.
Anticancer Res.
2010
30:327-37
PubMed ID: 20332436
|
|
8332
Matsuda K, Ohga N, Hida Y, Muraki C, Tsuchiya K, Kurosu T, Akino T, Shih SC, Totsuka Y, Klagsbrun M, Shindoh M, Hida K.
Isolated tumor endothelial cells maintain specific character during long-term culture.
Biochem. Biophys. Res. Commun.
2010
394:947-54
PubMed ID: 20302845
DOI: 10.1016/j.bbrc.2010.03.089
|
|
8356
Hosono T, Tanaka T, Tanji K, Nakatani T, Kamitani T.
NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation.
Br. J. Cancer
2010
102:873-82
PubMed ID: 20160729
DOI: 10.1038/sj.bjc.6605574
|
|
18946
El-Beialy W, Galal N, Deyama Y, Yoshimura Y, Suzuki K, Tei K, Totsuka Y.
Regulation of human and pig renal Na(+),K (+)-ATPase activity by tyrosine phosphorylation of their alpha(1)-subunits
J Membr Biol
2010
233(1-3):119-26
PubMed ID: 20130847
DOI: 10.1007/s00232-010-9231-z
|
|
6393
Inowa T, Hishikawa K, Matsuzaki Y, Isagawa T, Takeuchi T, Aburatani H, Kitamura T, Fujita T.
GADD45β Determines Chemoresistance and Invasive Growth of Side Population Cells of Human Embryonic Carcinoma.
Stem Cells Int
2010
2010:782967
PubMed ID: 21048853
DOI: 10.4061/2010/782967
|
|
6126
Akino T, Hida K, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Harabayashi T, Shinohara N, Nonomura K, Klagsbrun M, Shindoh M.
Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors.
Am J Pathol
2009
175(6):2657-67
PubMed ID: 19875502
DOI: 10.2353/ajpath.2009.090202
|
|
18123
Moriya F, Ogasawara S, Basaki Y, Akiba J, Kojiro S, Fukahori S, Ishizaki H, Nishida N, Matsuoka K, Kojiro M, Kuwano M, Yano H.
Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivo
Int J Oncol
2008
33(4):647-55
PubMed ID: 18813777
DOI: 10.1016/j.ijrobp.2008.06.320
|
|
12791
Fukuzawa M, Yamaguchi R, Hide I, Chen Z, Hirai Y, Sugimoto A, Yasuhara T, Nakata Y.
Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity
Biol Pharm Bull
2008
31(10):1933-7
PubMed ID: 18827358
DOI: 10.1248/bpb.31.1933
|
|
18947
Senda M, Ito A, Tsuchida A, Hagiwara T, Kaneda T, Nakamura Y, Kasama K, Kiso M, Yoshikawa K, Katagiri Y, Ono Y, Ogiso M, Urano T, Furukawa K, Oshima S, Furukawa K.
Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers
Biochem J
2007
402(3):459-70
PubMed ID: 17123352
DOI: 10.1042/BJ20061118
|
|
3396
Yamada, Daisuke, Kikuchi, Shinji, Williams, Yuko N, Sakurai-Yageta, Mika, Masuda, Mari, Maruyama, Tomoko, Tomita, Kyoichi, Gutmann, David H, Kakizoe, Tadao, Kitamura, Tadaichi, Kanai, Yae, Murakami, Yoshinori
Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma.
Int J Cancer
2006
118:916-23
PubMed ID: 16152585
DOI: 10.1002/ijc.21450
|
|
5012
Kawakami T, Chano T, Minami K, Okabe H, Okada Y, Okamoto K.
Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma.
Hum Mol Genet
2006
15(6):821-30
PubMed ID: 16439445
DOI: 10.1093/hmg/ddl001
|
|
14006
Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y, Katagiri T.
Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma
Int J Oncol
2006
29(4):799-827.
PubMed ID: 16964377
|
|
3164
Takamatsu, Shinji, Inoue, Noboru, Katsumata, Toshiyuki, Nakamura, Katsumi, Fujibayashi, Yasuhisa, Takeuchi, Makoto
The relationship between the branch-forming glycosyltransferases and cell surface sugar chain structures.
Biochemistry
2005
44:6343-9
PubMed ID: 15835923
DOI: 10.1021/bi047606a
|
|
3344
Chen, Qinzhong, Shinohara, Nobuo, Abe, Takashige, Watanabe, Takafumi, Nonomura, Katsuya, Koyanagi, Tomohiko
Significance of COX-2 expression in human renal cell carcinoma cell lines.
Int J Cancer
2004
108:825-32
PubMed ID: 14712483
DOI: 10.1002/ijc.11646
|
|
18945
Chen Q, Shinohara N, Abe T, Harabayashi T, Nonomura K.
Impact of cyclooxygenase-2 gene expression on tumor invasiveness in a human renal cell carcinoma cell line
J Urol
2004
172(6 Pt 1):2153-7
PubMed ID: 15538221
DOI: 10.1097/01.ju.0000143440.08760.3a
|
|
2661
Kasuya, Yutaka, Hosaka, Yoshio, Matsushima, Hisashi, Goto, Toshitaka, Kitamura, Tadaichi, Okuyama, Akira
Prominent induction of cyclin B1 in G2/M renal cancer cells with butyrolactone 1.
Int J Urol
2003
10:323-31
PubMed ID: 12757604
DOI: 10.1046/j.1442-2042.2003.00626.x
|
|
2548
Sudo, Tatsuhiko, Yagasaki, Yuki, Hama, Hiroshi, Watanabe, Naoko, Osada, Hiroyuki
Exip, a new alternative splicing variant of p38 alpha, can induce an earlier onset of apoptosis in HeLa cells.
Biochem Biophys Res Commun
2002
291:838-43
PubMed ID: 11866441
DOI: 10.1006/bbrc.2002.6529
|
|
2561
Kasuya Y, Hosaka Y, Matsushima H, Goto T, Kitamura T
Differences in cell kinetic changes among renal cancer cell lines treated with interferon-alpha.
Int J Urol
2001
8:449-54
PubMed ID: 11555012
DOI: 10.1046/j.1442-2042.2001.00346.x
|
|
2441
Tsurushima H, Liu SQ, Tuboi K, Matsumura A, Yoshii Y, Nose T, Saijo K, Ohno T.
Reduction of end-stage malignant glioma by injection with autologous cytotoxic T lymphocytes
Jpn J Cancer Res
1999
90(5):536-45
PubMed ID: 10391094
DOI: 10.1111/j.1349-7006.1999.tb00781.x
|
|
2318
Liu SQ, Kawai K, Shiraiwa H, Hayashi H, Akaza H, Hashizaki K, Shiba R, Saijo K, Ohno T.
High rate of induction of human autologous cytotoxic T lymphocytes against renal carcinoma cells cultured with an interleukin cocktail.
Jpn J Cancer Res
1998
89(11):1195-201
PubMed ID: 9914789
DOI: 10.1111/j.1349-7006.1998.tb00515.x
|
|
2385
Shinohara N, Ogiso Y, Tanaka M, Sazawa A, Harabayashi T, Koyanagi T.
The significance of Ras guanine nucleotide exchange factor, son of sevenless protein, in renal cell carcinoma cell lines
J Urol
1997
158(3 Pt 1):908-11
PubMed ID: 9258117
DOI: 10.1097/00005392-199709000-00070
|
|
2061
Sugimoto H, Nishino H
[Effect of recombinant human basic fibroblast growth factor (bFGF) on the growth of human tumor cell lines]
Hum Cell
1996
9:129-40
PubMed ID: 9183641
|
|
17992
Inoue M, Yano H, Kojiro M.
Expression of Fas and anti-Fas-mediated apoptosis in human renal cell carcinoma
Int J Oncol
1996
9(1):49-56
PubMed ID: 21541480
DOI: 10.3892/ijo.9.1.49
|
|
2122
Liu, S Q, Shiraiwa H, Kawai K, Hayashi H, Akaza H, Kim, B S, Oki A, Nishida M, Kubo T, Hashizaki K, Saijo K, Ohno T
Tumor-Specific Autologous Cytotoxic T Lymphocytes from Tissue Sections
Nat Med
1996
2(12):1283
PubMed ID: 8946818
DOI: 10.1038/nm1296-1283
|
|
17231
Ogose A, Motoyama T, Hotta T, Watanabe H.
Expression of bone morphogenetic proteins in human osteogenic and epithelial tumor cells
Pathol Int
1996
46(1):9-14
PubMed ID: 10846544
DOI: 10.1111/j.1440-1827.1996.tb03527.x
|
|
1902
Shu Qin Liu, Kaoru Saijo, Makoto Kodama, Tadao Ohno
Intelligent matrices for tumor-specific cytotoxic T lymphocytes
Materials Science and Engineering: C
1994
2:61-65
DOI: 10.1016/0928-4931(94)90030-2
|
Back
Top
CELL BANK Website
